reports
- ABGSC Financials Research
- Jan Erik Gjerland
- Patrik Brattelius
- Ahmed Ben Salem
- Baptiste Lebacq
ODDO : More cautious scenario amidst tensions on trade tariffs
The recent announcement of the application of trade tariffs by the Trump administration led to a sharp correction in oil prices amidst fears of an economic slowdown as a result of a full-blown trade war. We are adopting a more cautious scenario, with oil prices now expected to reach $ 67/b for 2025, $ 65/b for 2026 and $ 67/b in the longer term. Our 2025-2030 capex scenario has been lowered by 5% and our EPS expectations by 13% on average over 2025-2027, whilst our target prices have been lowere...
FP TOTAL SE
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
SLB.N SCHLUMBERGER NV
GTT GAZTRANSPORT & TECHNIGAZ SA
SBMO SBM OFFSHORE NV
OMV OMV AG
ENI ENI S.P.A.
P2F PETROFAC LIMITED
REP REPSOL SA
TUB TUBACEX S.A.
SOC SUBSEA 7 S.A.
PKN POLSKI KONCERN NAFTOWY ORLEN S.A.
SBO SCHOELLER-BLECKMANN OILFIELD EQUIPMENT AG
TRE TECNICAS REUNIDAS SA
TEC TECHNIPFMC PLC
SNG SOCIETATEA NATIONALA DE GAZE NATURALE ROMGAZ SA
SNP PETROM S.A.
BP. BP P.L.C.
MOL MOL HUNGARIAN OIL & GAS PLC CLASS A
VK VALLOUREC SA
TE TECHNIP ENERGIES NV
FUR FUGRO NV
SHEL SHELL PLC
SPM SAIPEM S.P.A.
TEN TENARIS S.A.
VIRI VIRIDIEN
Transaction in Own Shares
Transaction in Own Shares Transaction in Own Shares 14 April, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 14 April 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 14/04/2025 900,000 £ 23.8400 £ 23.4900 £ 23.6546 LSE GBP 14/04/2025 0 - - - Chi-X (CXE) GBP 14/04/2025 0 - - - BATS (BXE...
EVS Broadcast Equipment reports update of share buyback program
EVS Broadcast Equipment reports update of share buyback program EVS reports update of share buyback program Liège, Belgium | April 14, 2025 EVS Broadcast Equipment reports that the following transactions, conducted within the framework of the share buyback program announced on November 25, 2024, took place between April 7 and 11, 2025: Trade DateNumber of shares acquiredAverage price (EUR)Highest price (EUR)Lowest price (EUR)Total (EUR)Market07-04-254,00032.258533.2031.35129,034XBRU08-04-254,00034.482235.3033.55137,929XBRU09-04-254,00033.581034.0033.00134,324XBRU10-04-254,000...
EVS Broadcast Equipment: update du programme de rachat d’actions propr...
EVS Broadcast Equipment: update du programme de rachat d’actions propres EVS publie un update de son programme de rachat d'actions propres Liège, Belgique | Le 14 avril 2025 EVS Broadcast Equipment rapporte que les transactions suivantes, réalisées dans le cadre du programme de rachat d'actions annoncé le 25 novembre 2024, ont eu lieu entre le 7 et le 11 avril 2025: Date de la transactionNombre d’actions acquisesPrix moyen (EUR)Prix le plus haut (EUR)Prix le plus bas (EUR)Total (EUR)Marché07-04-254.00032,258533,2031,35129.034XBRU08-04-254.00034,482235,3033,55137.929XBRU09-04-254.00033...
Umicore - Transparency notification by Baillie Gifford & Co
Umicore - Transparency notification by Baillie Gifford & Co Transparency notification by Baillie Gifford & Co In accordance with article 14, § 1 of the law of 2 May 2007 on the disclosure of major holdings, Umicore was recently notified by Bailie Gifford & Co that it has crossed the legal threshold of 5% for the direct voting rights downwards on April 8th 2025. The total holding of direct voting rights and equivalent financial instruments of Baillie Gifford & Co now stands at 4.98%. Summary of the move: Date on which the threshold was crossedDate of notificationDirect voting r...
Umicore - Déclaration de transparence par Baillie Gifford & Co
Umicore - Déclaration de transparence par Baillie Gifford & Co Déclaration de transparence par Baillie Gifford & Co Conformément à l'article 14, § 1 de la loi du 2 mai 2007 relative à la publicité des participations importantes, Umicore a récemment été notifiée par Baillie Gifford & Co qu'elle a franchi le seuil légal de 5% des droits de vote directs, à la baisse le 8 avril 2025. La détention totale des droits de vote directs et des instruments financiers équivalents de Baillie Gifford & Co s'élève désormais à 4,98%. Résumé de la transaction : Date de franchissement du seuilDate de la ...
Umicore - Transparantieverklaring van Baillie Gifford & Co
Umicore - Transparantieverklaring van Baillie Gifford & Co Transparantieverklaring van Baillie Gifford & Co In overeenstemming met artikel 14, § 1 van de wet van 2 mei 2007 betreffende de openbaarmaking van belangrijke deelnemingen, werd Umicore onlangs op de hoogte gebracht door Baillie Giffrod & Co de statutaire drempel van 5% voor directe stemrechten heeft onderschreden op 8 april 2025. Het totale bezit van directe stemrechten en gelijkwaardige financiële instrumenten van Baillie Gifford & Co bedraagt nu 4,98 %. Samenvatting van de transactie: Datum van drempeloverschrijdingDatum...
Nexalin Technology Secures USPTO Patent for Deep Intracranial Frequenc...
Nexalin Technology Secures USPTO Patent for Deep Intracranial Frequency Stimulation (DIFS™) Technology in Treating Substance Use Disorders Patent Approval Reinforces Nexalin’s Leadership in Non-Invasive Brain Stimulation for Addiction Treatment HOUSTON, TX, April 14, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, is pleased to announce that the United States Patent and Trademark Office (USPTO) has officially granted its patent titled "Alternating Current Dynam...
THEON publishes its FY 2024 Annual Report - Strong financial performan...
THEON publishes its FY 2024 Annual Report - Strong financial performance and significant milestones achieved Further strong growth anticipated in FY 2025 PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS) 14 April 2025 – Theon International Plc (THEON) today publishes its FY 2024 Annual Report for the 12 months ended 31 December 2024, with the results demonstrating a very strong performance and achievement of significant milestones throughout the year. Financial Highlights Order intake of €466 m, reflecting a book-to-bill ratio of 1.3xSoft backlog at €654 m, up 21.1% y-o-y, equival...
- Francesco Pesole
- James Knightley
Bank of Canada preview: A hold is slightly more likely
The USMCA exemption from tariffs means that the risks to the Canadian outlook have slightly abated. There is still a tangible risk that the Bank of Canada will cut rates again on 16 April, but we marginally favour a hold – also considering the proximity to federal elections. USD/CAD is cheap below 1.40, but the USD confidence crisis may take time to unwind
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of S.F. Holding Co., Ltd. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 8 April 2025 in which we reassessed the appropriateness of the ratings in the contex...
CRCAM Alpes Provence : déclarations_Hebdomadaires_CAAP_S15-2025
CRCAM Alpes Provence : déclarations_Hebdomadaires_CAAP_S15-2025 CAISSE REGIONALE DE CREDIT AGRICOLE MUTUEL ALPES PROVENCE Société coopérative à capital variable25, Chemin des trois cyprès 13097 Aix en Provence Cedex 2381 976 448 R.C.S Aix en Provence Aix-en-Provence, le 14 avril 2025 Achats effectués dans les conditions de l'article 5 du règlement abus de marché dans le cadre du programme de rachat des Certificats Coopératifs d’Investissement autorisé par l’Assemblée Générale Mixte des sociétaires du 26 mars 2024. Le détail des t...
Net Asset Value(s)
Net Asset Value(s) 14 April 2025 HARGREAVE HALE AIM VCT PLC (the “Company”) NAV announcement As at close of business on 11 April 2025, the unaudited Net Asset Value (NAV) for Hargreave Hale AIM VCT plc was as follows: NAV per Ordinary share of 1p – 33.60 pence. END For further information, please contact: JTC (UK) LimitedUloma AdighibeAlexandria Tivey 7 1 LEI: 213800LRYA19A69SIT31
Wereldhave strengthens position in Tilburg with strategic acquisition ...
Wereldhave strengthens position in Tilburg with strategic acquisition of adjacent units Wereldhave has reached agreement with a single family office on the acquisition of three retail units at Pieter Vreedeplein in Tilburg (The Netherlands) with a total gross leasable area of 2,756 m². With the newly acquired units leased to mixed-use tenants, the acquisition will further strengthen the successful Full Service Center in the heart of the city. The total purchase price amounts to € 5.4m, including transaction costs, reflecting a net initial yield of 11% - well above Wereldhave’s current inter...
- Thijs Berkelder
AB Science receives notice of allowance for Unites States patent cover...
AB Science receives notice of allowance for Unites States patent covering masitinib until 2040 in the treatment of sickle cell disease PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR UNITED STATES PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL DISEASE Paris, April 14, 2025, 6pm CET AB Science SA (Euronext - FR0010557264 - AB) today announced that the United States Patent Office has issued a Notice of Allowance for a patent relating to methods of treating sickle cell disease (i.e. a medical use patent) with its lead compound masitinib, based on preclinical...
AB Science reçoit un avis d’acceptation pour le brevet américain coura...
AB Science reçoit un avis d’acceptation pour le brevet américain courant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose COMMUNIQUE DE PRESSE AB SCIENCE REÇOIT UN AVIS D'ACCEPTATION POUR LE BREVET AMERICAIN COUVRANT JUSQU'EN 2040 LE MASITINIB DANS LE TRAITEMENT DE LA DREPANOCYTOSE Paris, 14 avril 2025, 18h AB Science SA (Euronext - FR0010557264 - AB) annonce aujourd'hui que l'Office des brevets des Etats-Unis a délivré un avis d'acceptation pour un brevet portant sur des méthodes (c'est-à-dire un brevet d'utilisation médicale) de traitement de la drépanocytose...
Rexel : Déclaration des transactions sur actions propres du 7 avril au...
Rexel : Déclaration des transactions sur actions propres du 7 avril au 11 avril 2025 COMMUNIQUE DECLARATION DES TRANSACTIONS SUR ACTIONS PROPRES REALISEES DU 7 AVRIL AU 11 AVRIL 2025 Dans le cadre de l’autorisation consentie par l’Assemblée générale pour opérer sur ses actions et conformément à la règlementation relative aux rachats d’actions, Rexel déclare ci-après les achats d’actions propres réalisés du 7 avril au 11 avril 2025 : Nom de l'émetteurCode Identifiant de l'émetteurJour de la transactionCode identifiant de l'instrument financierVolume total journalier(en nombre d'actions)Pri...
Ipsen - March 2025 - Monthly information relative to the total number ...
Ipsen - March 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers) Market: Euronext Paris ISIN Code: FR 0010259150LEI: 549300M6SGDPB4Z94P11 Date Total number of shares composing the share capital Total number of voting rights (1) 31 March 2025 83,814,526 Gross total* ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.